<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.4//EN" "ep-patent-document-v1-4.dtd"><ep-patent-document id="EP0822936A1" file="EP96914240NWA1.xml" lang="fr" doc-number="0822936" date-publ="19980211" kind="A1" country="EP" status="n" dtd-version="ep-patent-document-v1-4"><SDOBI lang="fr"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSE..PTIE......FI..........................................................</B001EP><B003EP>*</B003EP><B007EP>EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)</B007EP></eptags></B000><B100><B110>0822936</B110><B130>A1</B130><B140><date>19980211</date></B140><B190>EP</B190></B100><B200><B210>96914240.0</B210><B220><date>19960424</date></B220><B240><B241><date>19971014</date></B241></B240><B250>fr</B250><B251EP>fr</B251EP><B260>fr</B260></B200><B300><B310>19950005051</B310><B320><date>19950427</date></B320><B330><ctry>FR</ctry></B330></B300><B400><B405><date>19980211</date><bnum>199807</bnum></B405><B430><date>19980211</date><bnum>199807</bnum></B430></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  31/    42            A I                    </text></classification-ipcr><classification-ipcr sequence="2"><text>A61P   9/    00            A I                    </text></classification-ipcr><classification-ipcr sequence="3"><text>C07D 498/    04            A I                    </text></classification-ipcr><classification-ipcr sequence="4"><text>C07D 498/    20            A I                    </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>SUBSTITUIERTE TETRAHYDROPYRANO(3,2-A)OXAZOLONE, VERFAHREN FÜR IHRE HERSTELLUNG UND DIESE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN</B542><B541>en</B541><B542>NOVEL SUBSTITUTED TETRAHYDROPYRANO 3,2-d]OXAZOLONES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM</B542><B541>fr</B541><B542>NOUVELLES TETRAHYDROPYRANO 3,2-d]OXAZOLONES SUBSTITUEES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT</B542></B540></B500><B700><B710><B711><snm>ADIR ET COMPAGNIE</snm><adr><str>1 rue Carle Hébert</str><city>92415 Courbevoie Cédex</city><ctry>FR</ctry></adr></B711></B710><B720><B721><snm>BILLINGTON, David, C. Aston University</snm><adr><str>Dept. of Pharmaceutical and Biological Sciences</str><city>Birmingham B4 7ET</city><ctry>GB</ctry></adr></B721><B721><snm>PERRON-SIERRA, Françoise</snm><adr><str>37 bis, rue des Plantes</str><city>F-75014 Paris</city><ctry>FR</ctry></adr></B721><B721><snm>ATASSI, Ghanem</snm><adr><str>4, rue Joséphine</str><city>F-92210 Saint-Cloud</city><ctry>FR</ctry></adr></B721><B721><snm>PIERRE, Alain</snm><adr><str>52, rue de Montval</str><city>F-78160 Marly-le-Roi</city><ctry>FR</ctry></adr></B721><B721><snm>BURBRIDGE, Michael</snm><adr><str>42, rue de l'Alma</str><city>F-92400 Courbevoie</city><ctry>FR</ctry></adr></B721><B721><snm>GUILBAUD, Nicolas</snm><adr><str>24, rue Lefèvre</str><city>F-75015 Paris</city><ctry>FR</ctry></adr></B721></B720></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry></B840><B860><B861><dnum><anum>FR1996000629</anum></dnum><date>19960424</date></B861><B862>fr</B862></B860><B870><B871><dnum><pnum>WO1996033999</pnum></dnum><date>19961031</date><bnum>199648</bnum></B871></B870></B800></SDOBI></ep-patent-document>